We also ascertained that neither the PD-L1 tumor proportion score (TPS) nor the EGFR mutation subtype correlated with the expression of TLSs in early-stage EGFR-mutant lung adenocarcinoma patients. The gene discussed is EGFR; the disease is lung adenocarcinoma.